Volume 15, Number 7—July 2009
Research
Clusters of Multidrug-Resistant Mycobacterium tuberculosis Cases, Europe
Table 2
Country | Genotyped strains | European clusters, no. (%) | National clusters, no. (%) |
---|---|---|---|
Belgium† | 15 | 7 (47) | 7 (47) |
Croatia | 5 | 0 | 5 (100) |
Czech Republic | 11 | 3 (27) | – |
Denmark | 4 | 1 (25) | 1 (25) |
Estonia | 228 | 183 (80) | – |
Finland | 7 | 3 (43) | 5 (71) |
France | 63 | 10 (16) | 24 (38) |
Germany | 17 | 8 (47) | 9 (53) |
Ireland | 3 | 1 (33) | – |
Israel | 39 | 18 (46) | 32 (82) |
Italy | 25 | 0 | – |
Lithuania | 56 | 18 (32) | 43 (77) |
Netherlands | 44 | 11 (25) | 17 (39) |
Norway | 7 | 2 (29) | 2 (29) |
Slovenia | 2 | 0 | 2 (100) |
Spain | 50 | 7 (14) | 14 (28) |
Sweden | 21 | 9 (43) | 9 (43) |
Switzerland | 25 | 3 (12) | – |
United Kingdom |
50 |
4 (8) |
– |
Total | 672 | 288 (43) | 170 (51) |
*MDR TB, multidrug-resistant tuberculosis; –, not available.
†Includes only cases detected at the start of treatment.
References
- Aziz MA, Wright A, Laszlo A, DeMuynckA, Porels F, Van Deun A, et al. Epidemiology of antituberculosis drug resistance (the global project on anti-tuberculosis drug resistance surveillance): an updated analysis. Lancet. 2006;368:2142–54. DOIPubMedGoogle Scholar
- Zignol M, Hosseini MS, Wright A, Weezenbeek CL, Nunn P, Watt CJ, Global incidence of multidrug-resistant tuberculosis. J Infect Dis. 2006;194:479–85. DOIPubMedGoogle Scholar
- World Health Organization. Anti-tuberculosis drug resistance in the world. Fourth global report. WHO/HTM/TB/Geneva; 2008.394.
- World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis. Geneva: The Organization; 2006 [cited 2009 May 26]. Available from http://whqlibdoc.who.int/publications/2006/9241546956_eng.pdf
- Gandhi NR, Moll A, Sturm AW, Pawinski R, Govender T, Lalloo U, Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa.
- Shah NS, Wright A, Bai GH, Barrera L, Boulahbal F, Martín-Casabona N, Worldwide emergence of extensively drug-resistant tuberculosis. Emerg Infect Dis. 2007;13:380–7.PubMedGoogle Scholar
- Schwoebel V, Lambregts-van Weezenbeeck CS, Moro ML, Drobniewski F, Hoffner SE, Raviglione MC, Standardisation of antituberculosis drug resistance surveillance in Europe. Recommendations of a World Health Organization (WHO) and International Union against Tuberculosis and Lung Disease (IUATLD) Working Group. Eur Respir J. 2000;16:364–71.PubMedGoogle Scholar
- Glynn JR, Whiteley J, Bifani P, Kremer K, van Soolingen D. Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic review. Emerg Infect Dis. 2002;8:843–9.PubMedGoogle Scholar
- Murray M, Nardell E. Molecular epidemiology of tuberculosis: achievements and challenges to current knowledge. Bull World Health Organ. 2002;80:477–82.PubMedGoogle Scholar
- Tracevska T, Jansone I, Baumanis V, Marga O, Lillebaek T. Prevalence of Beijing genotype in Latvian multidrug-resistant Mycobacterium tuberculosis isolates. Int J Tuberc Lung Dis. 2003;7:1097–103.PubMedGoogle Scholar
- Krüüner A, Hoffner SE, Sillastu H, Danilovits M, Levina K, Svenson SB, Spread of drug-resistant pulmonary tuberculosis in Estonia. J Clin Microbiol. 2001;39:3339–45. DOIPubMedGoogle Scholar
- European Concerted Action on New Generation Genetic Markers and Techniques for the Epidemiology and Control of Tuberculosis. Beijing/W genotype Mycobacterium tuberculosis and drug resistance. Emerg Infect Dis. 2006;12:736–43.PubMedGoogle Scholar
- EuroTB and the national coordinators for tuberculosis surveillance in the WHO European Region. Surveillance of tuberculosis in Europe. Reports on multi-drug resistant tuberculosis. Institut de Veille Sanitaire, Saint-Maurice 2008; France [cited 2009 May 15]. Available from http://www.eurotb.org/mdr_tb_surveillance/pdf/MDR-TB_report6.pdf
- Heersma HF, Kremer K, van Embden JD. Computer analysis of IS6110 RFLP patterns of Mycobacterium tuberculosis. Methods Mol Biol. 1998;101:395–422.PubMedGoogle Scholar
- Laszlo A, Rahman M, Espinal M, Raviglione M. Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Reference Laboratory Network: five rounds of proficiency testing, 1994–1998. Int J Tuberc Lung Dis. 2002;6:748–56.PubMedGoogle Scholar
- Laszlo A, Rahman M, Raviglione M, Bustreo F. Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Laboratory Network: first round of proficiency testing. Int J Tuberc Lung Dis. 1997;1:231–8.PubMedGoogle Scholar
- EuroTB and the National Coordinators for Tuberculosis Surveillance in the WHO European Region. Surveillance of tuberculosis in Europe. Report on tuberculosis cases notified in 2006, Institut de Veille Sanitaire, Saint-Maurice, France. 2008 Mar.
- van Embden JD, Cave MD, Crawford JT, Dale JW, Eisenach KD, Gicquel B, Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol. 1993;31:406–9.PubMedGoogle Scholar
- Kamerbeek J, Schouls L, Kolk A, van Agtervale M, van Soolingen D, Kuijper S, Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol. 1997;35:907–14.PubMedGoogle Scholar
- Supply P, Lesjean S, Savine E, Kremer K, van Soolingen D, Locht C. Automated high-throughput genotyping for study of global epidemiology of Mycobacterium tuberculosis based on mycobacterial interspersed repetitive units. J Clin Microbiol. 2001;39:3563–71. DOIPubMedGoogle Scholar
- Kremer K, Glynn JR, Lillebaek T, Niemann S, Kurepina NE, Kreiswirth BN, Definition of the Beijing/W lineage of Mycobacterium tuberculosis on the basis of genetic markers. J Clin Microbiol. 2004;42:4040–9. DOIPubMedGoogle Scholar
- Manissero D, Fernandez de la Hoz K. Surveillance methods and case definition for extensively drug resistant TB (XDR-TB) and relevance to Europe: summary update. Euro Surveill 2006; 11(11):E061103.1.
- Supply P, Allix C, Lesjean S, Cadoso-Oelemann M, Rusch-Gerdes S, Willery E, Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis. J Clin Microbiol. 2006;44:4498–510. DOIPubMedGoogle Scholar
- Lambregts-van Weezenbeek CS, Sebek MM, van Gerven PJ, de Vries G, Verver S, Kalisvaart NA, Tuberculosis contact investigation and DNA fingerprint surveillance in the Netherlands: 6 years’ experience with nationwide cluster feedback and cluster monitoring. Int J Tuberc Lung Dis. 2003;7(Suppl 3):S463–70.PubMedGoogle Scholar
Page created: November 08, 2010
Page updated: November 08, 2010
Page reviewed: November 08, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.